Alternative C3 Complement System: Lipids and Atherosclerosis

DownLoad

Familial hypercholesterolemia (FH) is increasingly associated with inflammation, a phenotype that persists despite treatment with lipid lowering therapies. The alternative C3 complement system (C3), as a key inflammatory mediator, seems to be involved in the atherosclerotic process; however, the relationship between C3 and lipids during plaque progression remains unknown. The aim of the study was to investigate by a systems biology approach the role of C3 in relation to lipoprotein levels during atherosclerosis (AT) progression and to gain a better understanding on the effects of C3 products on the phenotype and function of human lipid-loaded vascular smooth muscle cells (VSMCs). By mass spectrometry and differential proteomics, we found the extracellular matrix (ECM) of human aortas to be enriched in active components of the C3 complement system, with a significantly different proteomic signature in AT segments. Thus, C3 products were more abundant in AT-ECM than in macroscopically normal segments. Furthermore, circulating C3 levels were significantly elevated in FH patients with subclinical coronary AT, evidenced by computed tomographic angiography. However, no correlation was identified between circulating C3 levels and the increase in plaque burden, indicating a local regulation of the C3 in AT arteries. In cell culture studies of human VSMCs, we evidenced the expression of C3, C3aR (anaphylatoxin receptor) and the integrin αMβ2 receptor for C3b/iC3b (RT-PCR and Western blot). C3mRNA was up-regulated in lipid-loaded human VSMCs, and C3 protein significantly increased in cell culture supernatants, indicating that the C3 products in the AT-ECM have a local vessel-wall niche. Interestingly, C3a and iC3b (C3 active fragments) have functional effects on VSMCs, significantly reversing the inhibition of VSMC migration induced by aggregated LDL and stimulating cell spreading, organization of F-actin stress fibers and attachment during the adhesion of lipid-loaded human VSMCs. This study, by using a systems biology approach, identified molecular processes involving the C3 complement system in vascular remodeling and in the progression of advanced human atherosclerotic lesions.
Keywords: atherosclerosis; cardiovascular disease; complement system; mass spectrometry; proteomics.

Reference

1. Garcia-Arguinzonis, Maisa, et al. "Alternative C3 complement system: lipids and atherosclerosis." International journal of molecular sciences 22.10 (2021): 5122. under Open Access license CC BY 4.0, without modification

• Activation of the Complement System by Urban Particulate Matter
• Adipsin Is a Potential Predictor for Preeclampsia in Early Pregnancy
• Antimicrobial Peptide as Complement System Modulator
• Autoantibodies Against the Complement Regulator Factor H in the Serum of Patients
• C4b Binding Protein Acts as an Innate Immune Effector Against Influenza A Virus
• Coagulation Complement Activation and Cerebral Hypoperfusion
• Complement Activation in the Central Nervous System
• Complement Pathway Activation Is Associated With COVID-19 Mortality
• Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Subjects
• Complement DAF is a modulator of influenza A virus lung immunopathology
• Complement Regulation in Human Tenocytes under the Influence of Anaphylatoxin C5a
• Dendrimer end-terminal motif-dependent evasion of complement activation
• Inhibition of complement C5a receptor protects lung cells and tissues
• Interference of the Zika Virus E-Protein With the MAC of the Complement System
• Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins
• Microglial trogocytosis and the complement system regulate axonal pruning in vivo
• Modulation of complement activation by pentraxin-3 in prostate cancer
• Monitoring of the Complement System Status in Patients
• Monoclonal Antibodies Capable of Inhibiting Complement Downstream of C5
• REV-ERBα mediates complement expression and diurnal regulation of phagocytosis
• SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation
• Specific Evolution and Gene Family Expansion of C3 and Regulatory CFH in Fish
• Syk facilitates phagosome-lysosome fusion by regulating actin-remodeling
• The allosteric modulation of complement C5 by knob domain peptides
• The solution structure of the complement deregulator FHR5 reveals a compact dimer
• Two human antibodies enhance binding of CFH by stabilizing the CFH binding site